Prostate cancer Trials in Bradenton, United States
Conditions / Prostate cancer / Bradenton, United States
Prostate cancer is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00124566 | Study of Irofulven in Patients With Hormone-refractory Prostate Cancer | COMPLETED | PHASE2 |
| NCT01393119 | Phase II, Dose Finding Study of GTx-758 | TERMINATED | PHASE2 |
| NCT04404894 | Long-Term Prospective Registry in Prostate Cancer Patients From Diverse Urology Practice Settings Following Prolaris® Testing | ACTIVE_NOT_RECRUITING | — |
| NCT01538628 | SpaceOAR System Pivotal Study | COMPLETED | PHASE3 |
| NCT02737332 | A Study to Evaluate Serum Testosterone Levels in Patients With Metastatic Castration-Resistant Prostate Cancer | COMPLETED | PHASE2 |
| NCT00450970 | Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC) | TERMINATED | PHASE3 |
| NCT02799745 | A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance | COMPLETED | PHASE2 |
| NCT05467176 | A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX | ACTIVE_NOT_RECRUITING | — |
| NCT02135445 | Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer | COMPLETED | PHASE2 |
| NCT04122976 | A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described | ACTIVE_NOT_RECRUITING | — |